Celyad Oncology
(NASDAQ:CYAD)
Celyad Oncology SA - American Depositary Shares is expected to split Monday, August 15, 2022 with a ratio of 1:5
Celyad Oncology SA - American Depositary Shares recently split on Friday, August 12, 2022 with a ratio of 1:3
$2.06
At close: Aug 11
$2.07
0.0100[0.49%]
PreMarket: 8:59AM EDT
Day High/Low- - -
52 Week High/Low1.51 - 4.11
Open / Close- / -
Float / Outstanding- / 22.6M
Vol / Avg.- / 160.2K
Mkt Cap46.5M
P/E-
50d Avg. Price1.88
Div / Yield-
Payout Ratio-
EPS-0.28
Total Float-

Celyad Oncology (NASDAQ:CYAD), Quotes and News Summary

Celyad Oncology (NASDAQ: CYAD)

Day High/Low- - -
52 Week High/Low1.51 - 4.11
Open / Close- / -
Float / Outstanding- / 22.6M
Vol / Avg.- / 160.2K
Mkt Cap46.5M
P/E-
50d Avg. Price1.88
Div / Yield-
Payout Ratio-
EPS-0.28
Total Float-
Sector: Health Care.Industry: Biotechnology
Celyad Oncology is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno Oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T and C-Cure. The firm has CYAD-01 and CYAD-02 programs in the pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Immuno-oncology operating segments.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Celyad Oncology Questions & Answers

Q
How do I buy Celyad Oncology (CYAD) stock?
A

You can purchase shares of Celyad Oncology (NASDAQ: CYAD) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Celyad Oncology's (CYAD) competitors?
Q
What is the target price for Celyad Oncology (CYAD) stock?
A

The latest price target for Celyad Oncology (NASDAQ: CYAD) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 0.09 expecting CYAD to fall to within 12 months (a possible -95.63% downside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Celyad Oncology (CYAD)?
A

The stock price for Celyad Oncology (NASDAQ: CYAD) is $2.06 last updated August 11, 2022, 5:48 PM UTC.

Q
Does Celyad Oncology (CYAD) pay a dividend?
A

The next Celyad Oncology (CYAD) dividend date is projected to be Monday, August 22, 2022.

Q
When is Celyad Oncology (NASDAQ:CYAD) reporting earnings?
A

Celyad Oncology’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Celyad Oncology (CYAD) going to split?
A

There is no upcoming split for Celyad Oncology.

Q
What sector and industry does Celyad Oncology (CYAD) operate in?
A

Celyad Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.